/Companies

MantleBio

DefunctYC S23

Founded 2023 · 7 employees · 10 known investors

Find your way into MantleBio

Sign up to see every warm intro you have to MantleBio

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the MantleBio team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

MantleBio provides a data management and analytics platform designed for biotech researchers and scientific teams. The platform integrates biological data, enables advanced bioinformatics analysis, and accelerates drug development and genomics research workflows.

Also known as DryBox Bio

Founders & leadership· Y Combinator alumni (S23)

MantleBio was founded in 2023 by Emily Damato and Madeline Schade.

EDEmily Damato
Emily DamatoCEO, Co-Founder2023–2025She previously held software development roles at GRAIL, Arsenal Bio, and The Broad Institute, and holds degrees in computer science and biology from MIT.
MSMadeline Schade
Madeline SchadeCTO, Co-Founder2023–2025She previously held software engineering roles at Google, Arsenal Bio, and GRAIL.

Investors · 10

Related companies · 10

BasedashBasedash is an AI-native business intelligence platform that uses natural language processing to let teams query databases, generate dashboards, and explore analytics without writing SQL. It includes a built-in semantic layer for defining trusted metrics and supports 750+ data integrations.
ManifoldManifold Bio combines AI-guided protein design with high-throughput in vivo screening to engineer tissue-targeted biologics and deliver therapeutic payloads to specific organs. The company develops a computational and experimental platform to optimize pharmacokinetics and biodistribution directly in living systems for drug discovery and development.
camelAIcamelAI is an AI-powered coding agent that enables users to build and deploy applications from natural language instructions without traditional development or deployment workflows. The platform targets software developers and businesses seeking rapid, on-demand application development across various use cases, with built-in integrations and persistent infrastructure.
MantleMantle provides AI-based automation for institutional investors such as state investment boards, collecting documents from email and investor portals and extracting data like capital calls, NAVs, and K-1s into auditable, source-linked records. Its tools support portfolio analytics, cash management, faster quarter-close reporting, and querying quarterly reports for cited answers.
MetoficoMetofico builds a no-code platform for analyzing large and complex datasets in life science research, allowing scientists without programming expertise to extract insights from neuroscience, behavioral tracking, and other experimental data. The tool aims to reduce the time researchers spend on data analysis tasks.
Mammoth BiosciencesMammoth Bio develops technology to read and write the code of life, operating in the biotechnology sector.
NeptyneNeptyne is a spreadsheet application with an integrated Python environment that allows users to write code alongside traditional spreadsheet formulas, with AI assistance for non-programmers. It enables users to build data-driven applications ranging from financial models to machine learning systems within a familiar spreadsheet interface.
LyonLyon trains a foundation model from scratch on a company's own customer event data, producing per-customer embeddings that power downstream predictions such as churn, credit risk, fraud, collections, income, and cross-sell. The model runs inside the customer's own cloud (AWS, GCP, or Azure) with the customer owning the weights and keeping data isolated.
Mustang BioMustang Bio in-licenses and develops next-generation therapies aimed at treating patients, operating in the biotechnology and therapeutics sector.
Talus BioTalus develops a proprietary platform that measures and modulates the regulome—the body's gene expression control system—in native cellular contexts. The company designs AI-driven compounds and uses functional proteomics to enable drug discovery for transcription factors and regulatory proteins implicated in oncology, rare disease, and immune dysfunction.

Companies working in the same space as MantleBio.

Legal entities · 1

corporate structure
MantleBio, Inc.

In the news

Frequently asked questions

What does MantleBio do?
MantleBio provides a data management and analytics platform designed for biotech researchers and scientific teams. The platform integrates biological data, enables advanced bioinformatics analysis, and accelerates drug development and genomics research workflows.
Who founded MantleBio?
MantleBio was founded by Emily Damato, Madeline Schade in 2023.
Who are MantleBio's investors?
MantleBio's investors include Eight Capital, Hawk Hill Ventures, Lobster Capital, The E14 Fund, Y Combinator, Andreessen Horowitz, Four Cities, Initialized Capital and 2 more.